Baxter Issues Voluntary Nationwide Recall of Cefazolin in Dextrose Injection, USP, 2G / 100ml(20mg /ml) Single-Dose Infusion Bag in 100ml Due to Particulate Matter Found in Solution
- Date
- Jul 24, 2026
- Company
- Baxter International Inc.
- Brand
- Baxter
- Product
- Cefazolin in Dextrose Injection
- Reason
- Particulate matter (cardboard) found in the solution.
- Hazard
- Other
- Source
- FDA
How to identify the product
- (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.
- The affected lots can be identified by locating the lot number and expiration date on the front of the product package and the label attached to the carton, as shown in the images below.
- The impacted product was distributed from 3/25/2025 to 6/30/2025 in the United States.
- Customers should immediately discontinue use of and return all affected units in accordance with their facility’s process.
- Baxter is contacting customers with instructions on how to identify and return the impacted product.
Product photos are on the official FDA page.
Facts are taken from the official notice. If anything here differs from it, the official notice is correct.